{
    "2019-06-18": [
        [
            {
                "time": "2019-07-15",
                "original_text": "Online pharmacy flags possible new impurity in blood pressure drug",
                "features": {
                    "keywords": [
                        "online pharmacy",
                        "impurity",
                        "blood pressure drug"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-24",
                "original_text": "Jazz's (JAZZ) New Sleep Drug Sunosi Gets Schedule IV Status",
                "features": {
                    "keywords": [
                        "Jazz",
                        "Sunosi",
                        "Schedule IV",
                        "sleep drug"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-09-18",
                "original_text": "Roche's Rozlytrek Gets Approval in Japan for Solid Tumors",
                "features": {
                    "keywords": [
                        "Roche",
                        "Rozlytrek",
                        "approval",
                        "Japan",
                        "solid tumors"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-04-10",
                "original_text": "Alcon Inc. -- Moody's assigns Baa2 ratings to Alcon Inc.'s unsecured debt facilities",
                "features": {
                    "keywords": [
                        "Alcon Inc.",
                        "Moody's",
                        "Baa2",
                        "ratings",
                        "unsecured debt"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}